Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Endoscopic Resection for Treating Extremely Well Differentiated Intestinal-type Adenocarcinoma (WHYX Lesion)

NCT01451034 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01451034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01451034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Endoscopic Resection for Treating Extremely Well Differentiated Intestinal-type Adenocarcinoma (WHYX Lesion)
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2009
Completion date
December 31, 2010
Enrollment
872 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extremely well differentiated intestinal-type adenocarcinoma, whyx lesion